ESR1 and neoplasm: However, under certain conditions (such as in younger individuals or high-estrogen environments), VD may paradoxically promote Th17 cell activation and tumor metastasis risk by upregulating osteopontin (OPN) or activating estrogen receptor pathways, among other mechanisms [9].